News for Providers
Top stories summarized by our editors
7/20/2018

SNMMI and other radiology associations, radiopharmaceutical vendors, patient groups and medical imaging companies sent a letter urging the Senate and House subcommittees on energy and water development to designate $20 million to supporting molybdenum-99 production in the US. Despite the American Medical Isotopes Production Act of 2012, domestic Mo-99 supply continues to be inadequate, the groups wrote.

More Summaries:
SNMMI
7/20/2018

Patients with breast, colon, lung or prostate cancer who received complementary therapies, such as traditional Chinese medicine, homeopathy, herbs or naturopathy, had a higher mortality risk, compared with those who only received chemotherapy, radiation or surgery, Yale University researchers reported in JAMA Oncology. The findings also showed an increased likelihood of refusing standard treatment among those who used complementary medicine, but CM was not tied to higher mortality risk after adjusting for treatment delays and refusal of conventional treatment.

Full Story:
HealthDay News
7/20/2018

The FDA put on partial hold an early-stage study for Mersana Therapeutics' XMT-1522, being assessed to treat patients with advanced HER2-expressing cancers of the breast, lung and stomach. The decision followed a patient death potentially linked to receiving the drug.

Full Story:
Reuters
More Summaries:
FDA, Mersana Therapeutics, cancer, Mersana
7/20/2018

A Clarivate Analytics report showed that the impact factor of SNMMI's Journal of Nuclear Medicine increased from 6.646 in 2016 to 7.439 in 2017, making it the fifth highest ranked medical imaging journal. "Among nuclear medicine journals, JNM continues to have the highest number of citations, the highest average five-year impact factor, the highest number of citable articles, and the highest influence score," said JNM Editor-in-Chief Dr. Johannes Czernin.

Full Story:
Radiology Business
7/19/2018

Local contracting, or purchasing directly from vendors instead of going through a group purchasing organization, can make sense for the specific spending needs of some hospitals. Suresh Nirody of Cincinnati Children's Hospital Medical Center said national GPO contracts can work for commodities while direct negotiation works better in other areas.

Full Story:
Forbes
7/19/2018

The health care sector reported eight major data breaches in the first half of 2018, down from 19 major breaches during the same period in 2017, according to a report released by the cybersecurity firm Cryptonite. However, the number of patient records breached in the first half of this year was a little over 1.9 million, compared with approximately 1.67 million records in the first half of 2017, researchers found.

More Summaries:
Cryptonite
7/19/2018

Using the OnePartner health information exchange enabled multispecialty practice Holston Medical Group to identify patients who are "habitual utilizers of services," access data from disparate EHRs across its system and streamline hospital processes, said CIO Wesley Combs. "If you understand value-based medicine and the economics of health care, regarding insurance, risk identification and stratification, it doesn't take any time for an HIE to give a return on investment in value-based contracting -- if you are starting to go at risk," Combs said.

7/19/2018

Babies born very preterm were seven times more likely to develop hearing loss, while those born moderately preterm and late-preterm were more than two times and 1.5 times as likely, respectively, compared with infants born at term, Finnish researchers reported in Pediatrics. The risk of visual impairment also decreased with advancing gestational age.

More Summaries:
intracranial hemorrhage
7/19/2018

Type 2 diabetes patients who took metformin and added or switched to sulfonylureas were at a 26% increased risk for myocardial infarction, compared with those who continued with metformin treatment alone, according to a study in The BMJ. Researchers used a cohort of 77,138 patients, aged 40 and older, and also found a 28% greater all-cause mortality risk and an almost eight-fold higher severe hypoglycemia rate per 1,000 patient-years among sulfonylurea users, compared with those on metformin monotherapy.

More Summaries:
metformin
7/19/2018

A study in The Journal of Clinical Endocrinology & Metabolism showed significant regional differences in the prevalence of stroke and coronary heart disease among Chinese adults with type 2 diabetes. Researchers analyzed data from the China National HbA1c Surveillance System involving 219,522 patients and found the highest standardized rate of CHD in Tianjin province, while the highest prevalence of stroke was in Heilongjiang province.

More Summaries:
CHD